Sign in

CIK 0001370053

  • Non-accelerated filer
  • Smaller reporting company

ANAPTYSBIO, INC

Sign in to watch
Ticker
ANAB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
203828755
Phone
+1 858-362-6295
Business address
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
Former names
ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$249,372
in 1 filing, $249K under 10b5-1 plans

Net −$249,372. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. RENTON HOLLINGS −$249K Director sold 31% of stake

Reading 67 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-06-08 LOUMEAU ERIC J COO, General Counsel Sale −2,500 $24.00 $60K 523
2022-06-08 LOUMEAU ERIC J COO, General Counsel Exercise or conversion · Employee Stock Option (Right to Buy) −2,500 83,000
2022-05-18 LOUMEAU ERIC J COO, General Counsel Sale −1,146 $20.50 $23K 523
2022-05-05 EcoR1 Capital, LLC 10% owner Purchase +668,237 $21.63 $14.5M 7,521,024
2022-05-05 EcoR1 Capital, LLC 10% owner Sale −668,237 $21.63 $14.5M 7,521,024
2022-03-21 Faga Daniel Interim CEO Grant or award +887,043 887,043
2022-02-10 Lizzul Paul F. Chief Medical Officer Grant or award · Stock Option (right to buy) +70,000 70,000
2022-02-10 Marquet Magda Director Grant or award · Stock Option (right to buy) +9,200 9,200
2022-02-10 Hamill Laura Director Grant or award · Stock Option (right to buy) +9,200 9,200
2022-02-10 Topper James N Director Grant or award · Stock Option (right to buy) +9,200 9,200
2022-02-10 Schmid John P. Director Grant or award · Stock Option (right to buy) +9,200 9,200
2022-02-10 Suria Hamza President, CEO Grant or award · Stock Option (right to buy) +200,000 200,000
2022-02-10 RENTON HOLLINGS Director Grant or award · Stock Option (right to buy) +9,200 9,200
2022-02-10 LOUMEAU ERIC J COO, General Counsel Grant or award · Stock Option (right to buy) +70,000 70,000
2022-02-10 MULROY DENNIS Chief Financial Officer Grant or award · Stock Option (right to buy) +70,000 70,000
2022-02-10 FENTON DENNIS M Director Grant or award · Stock Option (right to buy) +9,200 9,200
2022-02-10 Faga Daniel Director Grant or award · Stock Option (right to buy) +9,200 9,200
2022-02-10 Ware J. Anthony Director Grant or award · Stock Option (right to buy) +9,200 9,200
2021-12-20 Suria Hamza President, CEO Exercise or conversion +36,645 $1.12 $41K 105,245
2021-12-20 Suria Hamza President, CEO Sale −11,915 $34.89 $416K 93,330

Page 22 of 27 · 522 trades